PDF herunterladen
Semin Liver Dis 2021; 41(02): 128-135
DOI: 10.1055/s-0040-1716564
Review Article

Wearables, Physical Activity, and Exercise Testing in Liver Disease

Michael A. Dunn
1   Center for Liver Diseases, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
2   Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania
,
Matthew R. Kappus
3   Gastroenterology Division, Department of Medicine, Duke University School of Medicine, Durham, North Carolina
,
Pamela M. Bloomer
1   Center for Liver Diseases, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
2   Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania
,
Andres Duarte-Rojo
1   Center for Liver Diseases, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
2   Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania
,
Deborah A. Josbeno
4   Department of Physical Therapy, School of Health and Rehabilitation Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania
,
John M. Jakicic
5   Healthy Lifestyle Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
› Institutsangaben
› Weitere Informationen
   Lizenzen und Reprints

Abstract

Physical inactivity is a major cause of deterioration in all forms of advanced liver disease. It is especially important as a driver of the components of the metabolic syndrome, with nonalcoholic fatty liver disease rapidly becoming the dominant cause of liver-related death worldwide. Growing realization of the health benefits of moderate-to-vigorous physical activity has captured the interest of persons who desire to improve their health, including those at risk for chronic liver injury. They are increasingly adopting wearable activity trackers to measure the activity that they seek to improve. Improved physical activity is the key lifestyle behavior that can improve cardiorespiratory fitness, which is most accurately measured with cardiopulmonary exercise testing (CPET). CPET is showing promise to identify risk and predict outcomes in transplant hepatology. Team effort among engaged patients, social support networks, and clinicians supported by web-based connectivity is needed to fully exploit the benefits of physical activity tracking.

Keywords

physical activity trackers - cardiopulmonary exercise testing - cirrhosis - liver transplantation


Publikationsverlauf

Artikel online veröffentlicht:
14. Januar 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Younossi ZM, Loomba R, Rinella ME. et al. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 2018; 68 (01) 361-371
    CrossrefPubMedGoogle Scholar
  • 2 Chascsa DM, Lai JC, Dunn MA. et al. Patient and caregiver attitudes and practices of exercise in candidates listed for liver transplantation. Dig Dis Sci 2018; 63 (12) 3290-3296
    CrossrefPubMedGoogle Scholar
  • 3 Dunn MA, Josbeno DA, Schmotzer AR. et al. The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates. Liver Transpl 2016; 22 (10) 1324-1332
    CrossrefPubMedGoogle Scholar
  • 4 Macmanus R. Health Trackers: How Technology Is Helping Us to Monitor and Improve Our Health. Lanham, MD: Rowman and Littlefield; 2015
    Google Scholar
  • 5 Hoy MB. Personal activity trackers and the quantified self. Med Ref Serv Q 2016; 35 (01) 94-100
    CrossrefPubMedGoogle Scholar
  • 6 Statista. Wearable technology - statistics & facts. Accessed May 8, 2020 at: https://statista.com/topics/1556/wearable-technology
    PubMed
  • 7 Omura JD, Carlson SA, Paul P, Watson KB, Fulton JE. National physical activity surveillance: users of wearable activity monitors as a potential data source. Prev Med Rep 2016; 5: 124-126
    CrossrefPubMedGoogle Scholar
  • 8 Kononova A, Li L, Kamp K. et al. The use of wearable activity trackers among older adults: focus group study of tracker perceptions, motivators, and barriers in the maintenance stage of behavior change. JMIR Mhealth Uhealth 2019; 7 (04) e9832
    CrossrefPubMedGoogle Scholar
  • 9 Chung CF, Cook J, Bales E, Zia J, Munson SA. More than telemonitoring: health provider use and nonuse of life-log data in irritable bowel syndrome and weight management. J Med Internet Res 2015; 17 (08) e203
    CrossrefPubMedGoogle Scholar
  • 10 Henriksen A, Haugen Mikalsen M, Woldaregay AZ. et al. Using fitness trackers and smartwatches to measure physical activity in research: analysis of consumer wrist-worn wearables. J Med Internet Res 2018; 20 (03) e110
    CrossrefPubMedGoogle Scholar
  • 11 Acar G, Ozturk O, Golparvar AJ. et al. Wearable and flexible textile electrodes for biopotential signal monitoring: a review. Electronics (Basel) 2019; 8: 479
    PubMedGoogle Scholar
  • 12 Kraus WE, Janz KF, Powell KE. et al. 2018 PHYSICAL ACTIVITY GUIDELINES ADVISORY COMMITTEE*. Daily step counts for measuring physical activity exposure and its relation to health. Med Sci Sports Exerc 2019; 51 (06) 1206-1212
    CrossrefPubMedGoogle Scholar
  • 13 Pattullo V, Duarte-Rojo A, Soliman W. et al. A 24-week dietary and physical activity lifestyle intervention reduces hepatic insulin resistance in the obese with chronic hepatitis C. Liver Int 2013; 33 (03) 410-419
    CrossrefPubMedGoogle Scholar
  • 14 Hayashi F, Momoki C, Yuikawa M. et al. Nutritional status in relation to lifestyle in patients with compensated viral cirrhosis. World J Gastroenterol 2012; 18 (40) 5759-5770
    CrossrefPubMedGoogle Scholar
  • 15 Williams FR, Vallance A, Faulkner T. et al. Home-based exercise in patients awaiting liver transplantation: a feasibility study. Liver Transpl 2019; 25 (07) 995-1006
    CrossrefPubMedGoogle Scholar
  • 16 Chen HW, Ferrando A, White MG. et al. Home-based physical activity and diet intervention to improve physical function in advanced liver disease: a randomized pilot trial. Dig Dis Sci 2020; 65 (11) 329-335
    CrossrefPubMedGoogle Scholar
  • 17 Fleisher LA, Fleckenstein JF, Frank SM, Thuluvath PJ. Heart rate variability as a predictor of autonomic dysfunction in patients awaiting liver transplantation. Dig Dis Sci 2000; 45 (02) 340-344
    CrossrefPubMedGoogle Scholar
  • 18 Ates F, Topal E, Kosar F. et al. The relationship of heart rate variability with severity and prognosis of cirrhosis. Dig Dis Sci 2006; 51 (09) 1614-1618
    CrossrefPubMedGoogle Scholar
  • 19 Mani AR, Montagnese S, Jackson CD. et al. Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol 2009; 296 (02) G330-G338
    CrossrefPubMedGoogle Scholar
  • 20 Jansen C, Chatterjee DA, Thomsen KL. et al. Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90-day mortality. Aliment Pharmacol Ther 2019; 50 (05) 568-579
    CrossrefPubMedGoogle Scholar
  • 21 Tudor-Locke C, Han H, Aguiar EJ. et al. How fast is fast enough? Walking cadence (steps/min) as a practical estimate of intensity in adults: a narrative review. Br J Sports Med 2018; 52 (12) 776-788
    CrossrefPubMedGoogle Scholar
  • 22 Chen HW, Ferrando AA, Dunn MA, Kim WR, Duarte-Rojo A. Cadence from physical activity trackers for monitoring of home-based exercise intensity in advanced liver disease. Liver Transpl 2020; 26 (05) 718-721
    CrossrefPubMedGoogle Scholar
  • 23 Riebe D, Ehrman JK, Liguori G, Magel M. ACSM's Guidelines for Exercise Testing and Prescription. 10th ed. Philadelphia, PA: Wolters Kluwer; 2018
    Google Scholar
  • 24 American Thoracic Society, American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167 (02) 211-277
    CrossrefPubMedGoogle Scholar
  • 25 Lemyze M, Dharancy S, Wallaert B. Response to exercise in patients with liver cirrhosis: implications for liver transplantation. Dig Liver Dis 2013; 45 (05) 362-366
    CrossrefPubMedGoogle Scholar
  • 26 Oudiz RJ, Barst RJ, Hansen JE. et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol 2006; 97 (01) 123-126
    CrossrefPubMedGoogle Scholar
  • 27 Hennis PJ, Meale PM, Grocott MP. Cardiopulmonary exercise testing for the evaluation of perioperative risk in non-cardiopulmonary surgery. Postgrad Med J 2011; 87 (1030): 550-557
    CrossrefPubMedGoogle Scholar
  • 28 Junejo MA, Mason JM, Sheen AJ. et al. Cardiopulmonary exercise testing for preoperative risk assessment before hepatic resection. Br J Surg 2012; 99 (08) 1097-1104
    CrossrefPubMedGoogle Scholar
  • 29 Galant LH, Forgiarini Junior LA, Dias AS, Marroni CA. Maximum oxygen consumption predicts mortality in patients with alcoholic cirrhosis. Hepatogastroenterology 2013; 60 (125) 1127-1130
    PubMedGoogle Scholar
  • 30 Bernal W, Martin-Mateos R, Lipcsey M. et al. Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl 2014; 20 (01) 54-62
    CrossrefPubMedGoogle Scholar
  • 31 Prentis JM, Manas DM, Trenell MI, Hudson M, Jones DJ, Snowden CP. Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation. Liver Transpl 2012; 18 (02) 152-159
    CrossrefPubMedGoogle Scholar
  • 32 Ney M, Haykowsky MJ, Vandermeer B, Shah A, Ow M, Tandon P. Systematic review: pre- and post-operative prognostic value of cardiopulmonary exercise testing in liver transplant candidates. Aliment Pharmacol Ther 2016; 44 (08) 796-806
    CrossrefPubMedGoogle Scholar
  • 33 Forman DE, Arena R, Boxer R. American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Stroke Council. et al. Prioritizing functional capacity as a principal end point for therapies oriented to older adults with cardiovascular disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation 2017; 135 (16) e894-e918
    CrossrefPubMedGoogle Scholar
  • 34 Zenith L, Meena N, Ramadi A. et al. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol 2014; 12 (11) 1920.e2-1926.e2
    CrossrefPubMedGoogle Scholar
  • 35 Debette-Gratien M, Tabouret T, Antonini M-T. et al. Personalized adapted physical activity before liver transplantation: acceptability and results. Transplantation 2015; 99 (01) 145-150
    CrossrefPubMedGoogle Scholar
  • 36 Kruger C, McNeely ML, Bailey RJ. et al. Home exercise training improves exercise capacity in cirrhosis patients: role of exercise adherence. Sci Rep 2018; 8 (01) 99
    CrossrefPubMedGoogle Scholar
  • 37 Macías-Rodríguez RU, Ilarraza-Lomelí H, Ruiz-Margáin A. et al. Changes in hepatic venous pressure gradient induced by physical exercise in cirrhosis: results of a pilot randomized open clinical trial. Clin Transl Gastroenterol 2016; 7 (07) e180
    CrossrefPubMedGoogle Scholar
  • 38 Rogers RJ, Lang W, Barone Gibbs B. et al. Applying a technology-based system for weight loss in adults with obesity. Obes Sci Pract 2016; 2 (01) 3-12
    CrossrefPubMedGoogle Scholar
  • 39 Pellegrini CA, Verba SD, Otto AD, Helsel DL, Davis KK, Jakicic JM. The comparison of a technology-based system and an in-person behavioral weight loss intervention. Obesity (Silver Spring) 2012; 20 (02) 356-363
    CrossrefPubMedGoogle Scholar
  • 40 Finkelstein EA, Haaland BA, Bilger M. et al. Effectiveness of activity trackers with and without incentives to increase physical activity (TRIPPA): a randomised controlled trial. Lancet Diabetes Endocrinol 2016; 4: 983-995
    CrossrefPubMedGoogle Scholar
  • 41 Fried LP, Tangen CM, Walston J. Cardiovascular Health Study Collaborative Research Group. et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56 (03) M146-M156
    CrossrefPubMedGoogle Scholar
  • 42 Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant 2014; 14 (08) 1870-1879
    CrossrefPubMedGoogle Scholar
  • 43 Lai JC, Covinsky KE, Dodge JL. et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology 2017; 66 (02) 564-574
    CrossrefPubMedGoogle Scholar
  • 44 Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, Macías-Rodríguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl 2018; 24 (01) 122-139
    CrossrefPubMedGoogle Scholar
  • 45 Dunn MA, Rogal SS, Duarte-Rojo A, Lai JC. Physical function, physical activity, and quality of life after liver transplantation. Liver Transpl 2020; 26 (05) 702-708
    CrossrefPubMedGoogle Scholar
  • 46 Bellar A, Welch N, Dasarathy S. Exercise and physical activity in cirrhosis: opportunities or perils. J Appl Physiol (1985) 2020; 128 (06) 1547-1567
    CrossrefPubMedGoogle Scholar